Carcinogenicity of aspartame, methyleugenol, and isoeugenol

Lancet Oncol. 2023 Aug;24(8):848-850. doi: 10.1016/S1470-2045(23)00341-8. Epub 2023 Jul 13.

Authors

Elio Riboli¹, Frederick A Beland¹, Dirk W Lachenmeier¹, M Matilde Marques¹, David H Phillips¹, Eva Schernhammer¹, Abdul Afghan¹, Ricardo Assunção¹, Giovanna Caderni¹, J Christopher Corton¹, Gisela de Aragão Umbuzeiro¹, Daphne de Jong¹, Melanie Deschasaux-Tanguy¹, Allison Hodge¹, Junko Ishihara¹, Dan D Levy¹, Daniele Mandrioli¹, Marjorie L McCullough¹, Sarah A McNaughton¹, Takeshi Morita¹, Anne P Nugent¹, Kumiko Ogawa¹, Arun R Pandiri¹, Consolato M Sergi¹, Mathilde Touvier¹, Luoping Zhang¹, Lamia Benbrahim-Tallaa¹, Shirisha Chittiboyina¹, Danila Cuomo¹, Nathan L DeBono¹, Charlotte Debras¹, Aline de Conti¹, Fatiha El Ghissassi¹, Emma Fontvieille¹, Rhea Harewood¹, John Kaldor¹, Heidi Mattock¹, Elisa Pasqual¹, Gabrielle Rigutto¹, Hannah Simba¹, Eero Suonio¹, Susana Viegas¹, Roland Wedekind¹, Mary K Schubauer-Berigan¹, Federica Madia¹

Affiliation

¹ International Agency for Research on Cancer, Lyon, France.

PMID: 37454664
DOI: 10.1016/S1470-2045(23)00341-8

No abstract available

Publication types

News

MeSH terms

Aspartame* / adverse effects
Carcinogenicity Tests
Eugenol*
Humans

Substances

Aspartame
methyleugenol
isoeugenol
Eugenol

Grants and funding